MARIA DEL CARMEN MONTOLIU FELIX-rekin lankidetzan egindako argitalpenak (17)

2024

  1. Improved cognition after rifaximin treatment is associated with changes in intra- and inter-brain network functional connectivity

    Journal of Translational Medicine, Vol. 22, Núm. 1

2023

  1. Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  2. Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients

    International Journal of Molecular Sciences, Vol. 24, Núm. 19

2022

  1. Metabolic syndrome is associated with poor response to rifaximin in minimal hepatic encephalopathy

    Scientific Reports, Vol. 12, Núm. 1

  2. Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy

    International Journal of Molecular Sciences, Vol. 23, Núm. 20

  3. Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis

    Journal of Hepatology, Vol. 77, Núm. 6, pp. 1554-1563

2021

  1. A new score unveils a high prevalence of mild cognitive impairment in patients with nonalcoholic fatty liver disease

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients

    Scientific Reports, Vol. 11, Núm. 1

  3. Patients with minimal hepatic encephalopathy show altered thermal sensitivity and autonomic function

    Journal of Clinical Medicine, Vol. 10, Núm. 2, pp. 1-18

2020

  1. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-16

2019

  1. Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy

    Journal of Translational Medicine, Vol. 17, Núm. 1

2018

  1. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment

    Free Radical Research, Vol. 52, Núm. 1, pp. 118-133

  2. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Minimal hepatic encephalopathy is associated with expansion and activation of CD4+CD28-, Th22 and Tfh and B lymphocytes

    Scientific Reports, Vol. 7, Núm. 1

  2. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy

    PLoS ONE, Vol. 12, Núm. 10

  3. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients

    PLoS ONE, Vol. 12, Núm. 2

2015

  1. Is Cognitive Impairment in Cirrhotic Patients Due to Increased Peroxynitrite and Oxidative Stress?

    Antioxidants and Redox Signaling, Vol. 22, Núm. 10, pp. 871-877